Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 

Preventive care recommendations to promote health equity

Our objective was to provide preventive care recommendations that promote health equity by prioritizing effective interventions for people experiencing disadvantages.

Guidelines | 2023
Equity, Clinical guidance

A Guide to Using Extended-Release Buprenorphine (Sublocade®) in Opioid Agonist Therapy (OAT)

Guidelines | 2023
Clinical guidance, Substitution/OAT

Prescription d’opioïdes : un rappel des bonnes pratiques

Guide | 2023
les guides de pratique clinique, à propos des prescripteurs, à propos des pharmaciens, la surdose, la mortalité, la politique / le cadre de réglementation

Point-of-care Emergency Clinical Summary: Treatment of Benzodiazepine Toxicity and the Use of Flumazenil

Guidelines | 2022
Overdose, Clinical guidance

Large Variation in Provincial Guidelines for Urine Drug Screening During Opioid Agonist Treatment in Canada

We conducted a policy scan of UDS guidelines, examining the published clinical practice guidelines for each Canadian province and extracting all relevant data in March 2017.

Guidelines | 2018
Clinical guidance, Substitution/OAT, About prescribers

Guide d’utilisation de la buprénorphine injectable à libération prolongée (SublocadeMC) dans le cadre d’un traitement par agonistes opioïdes (TAO)

Guide | 2023
les guides de pratique clinique, le traitement de substitution/TAO

Injection mensuelle de buprénorphine à libération prolongée

Guide | 2023
les guides de pratique clinique, à propos des prescripteurs, le traitement de substitution/TAO

Prescribed Safer Supply Protocols - Fentanyl Patch

Guidelines | 2023
Clinical guidance, Harm reduction, Safer supply, About prescribers

Urine Drug Testing in Clinical Practice

Guidelines | 2015
Clinical guidance, About prescribers

Extended-release monthly buprenorphine injection

Guidelines | 2023
Clinical guidance, About prescribers, Substitution/OAT

Collecting data on safer supply prescribing starts with correctly completing the duplicate prescription form

Guidelines | 2022
Clinical guidance, Safer supply, Policy/Regulatory, About prescribers

CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022

Guidelines | 2022
Clinical guidance, About prescribers

Emergency Department Toolkit for Opioid Use Disorder

Guidelines | 2022
About prescribers, Substitution/OAT, Hospitals, Clinical guidance

Prescribed Safer Supply Protocols: Fentanyl Patch

Guidelines | 2022
Clinical guidance, About prescribers, Policy/Regulatory, Safer supply

Recommandations pour la prise en charge de l’infection par le virus de l’hépatite C chez les usagers de drogues par injection

Guide | 2015
les guides de pratique clinique, les services enveloppants

Clinical Management of Opioid Withdrawal

Guidelines | 2022
Withdrawal, Clinical guidance, Harm reduction, About prescribers

Methadone treatment for patients who use fentanyl: Recommendations

Guidelines | 2021
Clinical guidance, Policy/Regulatory, About prescribers, Illegal drugs, Substitution/OAT, Carries/take-home doses

Methadone treatment for patients who use fentanyl: Plain language summary

Guidelines | 2021
Clinical guidance, Policy/Regulatory, About prescribers, Substitution/OAT, Carries/take-home doses, Illegal drugs

Opioid Use Disorder Practice Update

Guidelines | 2022
Clinical guidance, Policy/Regulatory, About prescribers, Harm reduction, Safer supply, Carries/take-home doses, Substitution/OAT

Methadone Take-Home Flexibilities Extension Guidance

Guidelines | 2022
Clinical guidance, Carries/take-home doses, Policy/Regulatory

Refine Your Search

Keywords
Format
Region